Abbvie Inc
BMV:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
BMV:ABBV
Watchlist
Price: 4 109.5698 MXN 0.31% Market Closed
Market Cap: 373.6B MXN

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 4 539.6721 MXN with a low forecast of 3 460.9254 MXN and a high forecast of 5 541.5669 MXN.

Lowest
Price Target
3 460.9254 MXN
16% Downside
Average
Price Target
4 539.6721 MXN
10% Upside
Highest
Price Target
5 541.5669 MXN
35% Upside
Abbvie Inc Competitors:
Price Targets
NRIX
Nurix Therapeutics Inc
50% Upside
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
BMEA
Biomea Fusion Inc
490% Upside
086900
Medy Tox Inc
12% Upside
RXRX
Recursion Pharmaceuticals Inc
72% Upside
300896
Imeik Technology Development Co Ltd
41% Upside
1530
3SBio Inc
55% Upside
2696
Shanghai Henlius Biotech Inc
78% Upside

Revenue
Forecast

Revenue Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

11%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

2%
Past Growth
65%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
4 539.6721 MXN

According to Wall Street analysts, the average 1-year price target for ABBV is 4 539.6721 MXN with a low forecast of 3 460.9254 MXN and a high forecast of 5 541.5669 MXN.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
65%

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

Back to Top